Mid-Year Report — JAMES P. KEESE for TEVA PHARMACEUTICALS USA (2007)

Firm

JAMES P. KEESE

Client

TEVA PHARMACEUTICALS USA

Income

$80,000

Expenses

—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R. 1038 Access to Life-Saving Medicine Act - all provisions S.1082 Food and Drug Administration Revitalization Act - all provisions S. 1088 Lower PRICED Drugs Act- all provisions S.1505 Affordable Biologics for Consumers Act - all provisions S. 1695 Biologics Price Competition and Innovation Act of 2007- all provisions H.R. 1956 The Patient Protection and Innovative Biologic Medicines Act - all provisions H.R. 2900 Food and Drug Administration Amendments Act of 2007 - all provisions S. 25, Citizen Petition Fairness and Accuracy Act of 2007 - all provisions S.623, Access to Life-Saving Medicine Act - all provisions S. 438, Fair Prescription Drug Competition Act - all provisions H.R. 806, Fair Prescription Drug Competition Act - all provisions

Lobbyist	Covered position, as disclosed
JAMES P KEESE	N/A

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); U.S. Trade Representative (USTR); Food & Drug Administration (FDA)

Bills named: H.R. 1956 (110th), S. 1088 (110th), S. 1695 (110th), S. 438 (110th), S. 623 (110th), S. 1505 (110th), S. 25 (110th), S. 1082 (110th), H.R. 2900 (110th), H.R. 806 (110th), H.R. 1038 (110th)

Medicare/Medicaid MMM

H.R.976 Children's Health Insurance Program Reauthorization Act of 2007 S.1893 Children's Health Insurance Program Reauthorization Act of 2007 H.R.3162 Children's Health and Medicare Protection Act of 2007

Lobbyist	Covered position, as disclosed
JAMES P KEESE	N/A

Contacted: Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); SENATE

Bills named: S. 1893 (110th), H.R. 3162 (110th), H.R. 976 (110th)

Trade (domestic/foreign) TRD

Matters relating to Israeli data exclusivity. Matters relating to pharmaceutical provisions in free trade agreements.

Lobbyist	Covered position, as disclosed
JAMES P KEESE	N/A

Contacted: Health & Human Services, Dept of (HHS); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Federal Trade Commission (FTC)

Copyright/Patent/Trademark CPT

H.R. 1902 Protecting Consumer Access to Generic Drugs Act - all provisions H.R. 1432, Preserve Access to Affordable Generics Act - all provisions S. 316, Preserve Access to Affordable Generics Act - all provisions H.R. 1908, Patent Reform Act of 2007 - all provisions S. 1145 Patent Reform Act of 2007 - all provisions

Lobbyist	Covered position, as disclosed
JAMES P KEESE	N/A

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC)

Bills named: S. 316 (110th), S. 1145 (110th), H.R. 1902 (110th), H.R. 1432 (110th), H.R. 1908 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.